Amelioration of insulin resistance by rosiglitazone is associated with increased adipose cell size in obese type 2 diabetic patients

References

• Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000; 106:473-81; PMID:10953022; http://dx.doi.org/10.1172/JCI10842
   PubMed Web of Science ®Google Scholar
• Danforth E Jr. Failure of adipocyte differentiation causes type II diabetes mellitus? Nat Genet 2000; 26:13; PMID:10973236; http://dx.doi.org/10.1038/79111
   PubMed Web of Science ®Google Scholar
• Unger RH. Lipotoxic diseases. Annu Rev Med 2002; 53:319-36; PMID:11818477; http://dx.doi.org/10.1146/annurev.med.53.082901.104057
   PubMed Web of Science ®Google Scholar
• Samuel VT, Petersen KF, Shulman GI. Lipid-induced insulin resistance: unravelling the mechanism. Lancet 2010; 375:2267-77; PMID:20609972; http://dx.doi.org/10.1016/S0140-6736(10)60408-4
   PubMed Web of Science ®Google Scholar
• Salans LB, Knittle JL, Hirsch J. The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity. J Clin Invest 1968; 47:153-65; PMID:16695937; http://dx.doi.org/10.1172/JCI105705
   PubMed Web of Science ®Google Scholar
• Krotkiewski M, Björntorp P, Sjöström L, Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 1983; 72:1150-62; PMID:6350364; http://dx.doi.org/10.1172/JCI111040
   PubMed Web of Science ®Google Scholar
• Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 2000; 43:1498-506; PMID:11151758; http://dx.doi.org/10.1007/s001250051560
   PubMed Web of Science ®Google Scholar
• Weyer C, Wolford JK, Hanson RL, Foley JE, Tataranni PA, Bogardus C, Pratley RE. Subcutaneous abdominal adipocyte size, a predictor of type 2 diabetes, is linked to chromosome 1q21–q23 and is associated with a common polymorphism in LMNA in Pima Indians. Mol Genet Metab 2001; 72:231-8; PMID:11243729; http://dx.doi.org/10.1006/mgme.2001.3147
   PubMedGoogle Scholar
• Lundgren M, Svensson M, Lindmark S, Renström F, Ruge T, Eriksson JW. Fat cell enlargement is an independent marker of insulin resistance and ‘hyperleptinaemia’. Diabetologia 2007; 50:625-33; PMID:17216279; http://dx.doi.org/10.1007/s00125-006-0572-1
   PubMed Web of Science ®Google Scholar
• Lönn M, Mehlig K, Bengtsson C, Lissner L. Adipocyte size predicts incidence of type 2 diabetes in women. FASEB J 2010; 24:326-31; PMID:19741173; http://dx.doi.org/10.1096/fj.09-133058
   PubMed Web of Science ®Google Scholar
• Arner P, Arner E, Hammarstedt A, Smith U. Genetic predisposition for Type 2 diabetes, but not for overweight/obesity, is associated with a restricted adipogenesis. PLoS One 2011; 6:e18284; PMID:21532749; http://dx.doi.org/10.1371/journal.pone.0018284
   PubMed Web of Science ®Google Scholar
• Paolisso G, Tataranni PA, Foley JE, Bogardus C, Howard BV, Ravussin E. A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 1995; 38:1213-7; PMID:8690174; http://dx.doi.org/10.1007/BF00422371
   PubMed Web of Science ®Google Scholar
• McLaughlin T, Sherman A, Tsao P, Gonzalez O, Yee G, Lamendola C, Reaven GM, Cushman SW. Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis. Diabetologia 2007; 50:1707-15; PMID:17549449; http://dx.doi.org/10.1007/s00125-007-0708-y
   PubMed Web of Science ®Google Scholar
• Yang J, Eliasson B, Smith U, Cushman SW, Sherman AS. The size of large adipose cells is a predictor of insulin resistance in first-degree relatives of type 2 diabetic patients. Obesity (Silver Spring) 2012; 20:932-8; PMID:22240722; http://dx.doi.org/10.1038/oby.2011.371
   PubMed Web of Science ®Google Scholar
• Berger J, Moller DE. The mechanisms of action of PPARs. Annu Rev Med 2002; 53:409-35; PMID:11818483; http://dx.doi.org/10.1146/annurev.med.53.082901.104018
   PubMed Web of Science ®Google Scholar
• Tontonoz P, Spiegelman BM. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 2008; 77:289-312; PMID:18518822; http://dx.doi.org/10.1146/annurev.biochem.77.061307.091829
   PubMed Web of Science ®Google Scholar
• de Souza CJ, Eckhardt M, Gagen K, Dong M, Chen W, Laurent D, Burkey BF. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes 2001; 50:1863-71; PMID:11473050; http://dx.doi.org/10.2337/diabetes.50.8.1863
   PubMed Web of Science ®Google Scholar
• Johnson JA, Trasino SE, Ferrante AW Jr., Vasselli JR. Prolonged decrease of adipocyte size after rosiglitazone treatment in high- and low-fat-fed rats. Obesity (Silver Spring) 2007; 15:2653-63; PMID:18070756; http://dx.doi.org/10.1038/oby.2007.317
   PubMedGoogle Scholar
• Hallakou S, Doaré L, Foufelle F, Kergoat M, Guerre-Millo M, Berthault MF, Dugail I, Morin J, Auwerx J, Ferré P. Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat. Diabetes 1997; 46:1393-9; PMID:9287037; http://dx.doi.org/10.2337/diabetes.46.9.1393
   PubMed Web of Science ®Google Scholar
• Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K, Umesono K, Akanuma Y, Fujiwara T, Horikoshi H, et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 1998; 101:1354-61; PMID:9502777; http://dx.doi.org/10.1172/JCI1235
   PubMed Web of Science ®Google Scholar
• Smith SR, Xie H, Baghian S, et al. Pioglitazone changes the distribution of adipocyte size in type 2 diabetes. Adipocytes 2006; 2:11-22
   Google Scholar
• McLaughlin TM, Liu T, Yee G, Abbasi F, Lamendola C, Reaven GM, Tsao P, Cushman SW, Sherman A. Pioglitazone increases the proportion of small cells in human abdominal subcutaneous adipose tissue. Obesity (Silver Spring) 2010; 18:926-31; PMID:19910937; http://dx.doi.org/10.1038/oby.2009.380
   PubMed Web of Science ®Google Scholar
• Boden G, Cheung P, Mozzoli M, Fried SK. Effect of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetes. Metabolism 2003; 52:753-9; PMID:12800103; http://dx.doi.org/10.1016/S0026-0495(03)00055-6
   PubMed Web of Science ®Google Scholar
• Shadid S, Jensen MD. Effects of pioglitazone versus diet and exercise on metabolic health and fat distribution in upper body obesity. Diabetes Care 2003; 26:3148-52; PMID:14578253; http://dx.doi.org/10.2337/diacare.26.11.3148
   PubMed Web of Science ®Google Scholar
• Koenen TB, Tack CJ, Kroese JM, Hermus AR, Sweep FC, van der Laak J, Stalenhoef AF, de Graaf J, van Tits LJ, Stienstra R. Pioglitazone treatment enlarges subcutaneous adipocytes in insulin-resistant patients. J Clin Endocrinol Metab 2009; 94:4453-7; PMID:19820024; http://dx.doi.org/10.1210/jc.2009-0517
   PubMed Web of Science ®Google Scholar
• Pasarica M, Xie H, Hymel D, Bray G, Greenway F, Ravussin E, Smith SR. Lower total adipocyte number but no evidence for small adipocyte depletion in patients with type 2 diabetes. Diabetes Care 2009; 32:900-2; PMID:19228873; http://dx.doi.org/10.2337/dc08-2240
   PubMed Web of Science ®Google Scholar
• Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85:2402-10; PMID:10902785; http://dx.doi.org/10.1210/jcem.85.7.6661
   PubMed Web of Science ®Google Scholar
• McLaughlin T, Deng A, Yee G, Lamendola C, Reaven G, Tsao PS, Cushman SW, Sherman A. Inflammation in subcutaneous adipose tissue: relationship to adipose cell size. Diabetologia 2010; 53:369-77; PMID:19816674; http://dx.doi.org/10.1007/s00125-009-1496-3
   PubMed Web of Science ®Google Scholar
• McLaughlin T, Lamendola C, Coghlan N, Liu TC, Lerner K, Sherman A, Cushman SW. Subcutaneous adipose cell size and distribution: relationship to insulin resistance and body fat. Obesity (Silver Spring) 2014; 22:673-80; PMID:23666871; http://dx.doi.org/10.1002/oby.20209
   PubMed Web of Science ®Google Scholar
• MacKellar J, Cushman SW, Periwal V. Waves of adipose tissue growth in the genetically obese Zucker fatty rat. PLoS One 2010; 5:e8197; PMID:20107501; http://dx.doi.org/10.1371/journal.pone.0008197
   PubMed Web of Science ®Google Scholar
• Gustafson B, Smith U. The WNT inhibitor Dickkopf 1 and bone morphogenetic protein 4 rescue adipogenesis in hypertrophic obesity in humans. Diabetes 2012; 61:1217-24; PMID:22447857; http://dx.doi.org/10.2337/db11-1419
   PubMedGoogle Scholar
• Larson-Meyer DE, Heilbronn LK, Redman LM, Newcomer BR, Frisard MI, Anton S, Smith SR, Alfonso A, Ravussin E. Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects. Diabetes Care 2006; 29:1337-44; PMID:16732018; http://dx.doi.org/10.2337/dc05-2565
   PubMed Web of Science ®Google Scholar
• Hirsch J, Knittle JL. Cellularity of obese and nonobese human adipose tissue. Fed Proc 1970; 29:1516-21; PMID:5459900
   PubMedGoogle Scholar
• Jo J, Gavrilova O, Pack S, Jou W, Mullen S, Sumner AE, Cushman SW, Periwal V. Hypertrophy and/or Hyperplasia: Dynamics of Adipose Tissue Growth. PLoS Comput Biol 2009; 5:e1000324; PMID:19325873; http://dx.doi.org/10.1371/journal.pcbi.1000324
   PubMed Web of Science ®Google Scholar
• Jo J, Guo J, Liu T, Mullen S, Hall KD, Cushman SW, Periwal V. Hypertrophy-driven adipocyte death overwhelms recruitment under prolonged weight gain. Biophys J 2010; 99:3535-44; PMID:21112277; http://dx.doi.org/10.1016/j.bpj.2010.10.009
   PubMed Web of Science ®Google Scholar
• Franck N, Stenkula KG, Ost A, Lindström T, Strålfors P, Nystrom FH. Insulin-induced GLUT4 translocation to the plasma membrane is blunted in large compared with small primary fat cells isolated from the same individual. Diabetologia 2007; 50:1716-22; PMID:17572871; http://dx.doi.org/10.1007/s00125-007-0713-1
   PubMed Web of Science ®Google Scholar
• Jernås M, Palming J, Sjöholm K, Jennische E, Svensson PA, Gabrielsson BG, Levin M, Sjögren A, Rudemo M, Lystig TC, et al. Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J 2006; 20:1540-2; PMID:16754744; http://dx.doi.org/10.1096/fj.05-5678fje
   PubMed Web of Science ®Google Scholar